TGA Approval

NULOJIX belatacept (rch) 250mg powder for IV infusion vial (179687)

ARTG ID

179687

ARTG Name

NULOJIX belatacept (rch) 250mg powder for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

March 15, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

Ingredient Name

Belatacept

Empowering clinical research with data-driven insights and AI-powered tools.

NULOJIX belatacept (rch) 250mg powder for IV infusion vial (179687) - TGA 批准文号 | MedPath